Article
As gene therapy research continues to expand within the nAMD space, major factors should be considered, including long efficacy and durability of the therapeutic payload, safety profile, and overall expenditures to the health care system.
Volume 21 Issue April 01/04/2024
The Retinal Physician Video Channel highlights developments and insights in retina science and patient care. Join Retinal Physician Editor-in-Chief, Peter K. Kaiser, MD, and leading clinicians as they share perspective and insight on the latest clinical innovations and case studies. Follow the series on your phone! Text RPVideo to 833-736-0674
View Channel
In the Retinal Physician Geographic Atrophy Video Channel, editor in chief Peter Kaiser, MD, invites expert guests to discuss treatment of geographic atrophy, including patient selection, treatment initiation, and managing treatment challenges.
This content is independent editorial sponsored by Astellas. Astellas had no input in the development of this content.
RPS 2023 was a huge success! If you were able to join us, for the live, virtual event on September 23, please be sure to claim your CE credit by October 13. If you were not able to join us, please take some time to view the On-Demand sessions, which will be available beginning October 2 – November 1, 2023.
